Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amy R Pettit

Showing results (11-20 of 31) with videos related to

Pageof 4
Sort By:
The American Journal of Managed Care|March 30, 2016
Impact of cost sharing on specialty drug utilization and outcomes: a review of the evidence and future directionsJalpa A Doshi, Pengxiang Li, Vrushabh P Ladage, et al.
Journal of Clinical Psychopharmacology|June 16, 2015
Concurrent Oral Antipsychotic Drug Use Among Schizophrenia Patients Initiated on Long-Acting Injectable Antipsychotics Post-Hospital DischargeJalpa A Doshi, Amy R Pettit, Jeffrey J Stoddard, et al.
The American Journal of Managed Care|April 13, 2018
Reducing out-of-pocket cost barriers to specialty drug use under Medicare Part D: addressing the problem of "too much too soon"Jalpa A Doshi, Pengxiang Li, Amy R Pettit, et al.
Hospital Pediatrics|October 21, 2021
Depression and Anxiety Symptoms During and After Pediatric Asthma HospitalizationHaley Morin, Diana Worsley, Xuemei Zhang, et al.
Health Services Research|July 25, 2017
Impact of Cost-Sharing Increases on Continuity of Specialty Drug Use: A Quasi-Experimental StudyPengxiang Li, Tianyan Hu, Xinyan Yu, et al.
The American Journal of Managed Care|June 9, 2016
High cost sharing and specialty drug initiation under Medicare Part D: a case study in patients with newly diagnosed chronic myeloid leukemiaJalpa A Doshi, Pengxiang Li, Hairong Huo, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|March 2, 2020
Trends and Factors Associated With Insurer Approval of Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitor PrescriptionsJalpa A Doshi, Pengxiang Li, Justin T Puckett, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|June 15, 2022
Stakeholder Perspectives on MAPSAmanda L Sanchez, Katelin Hoskins, Amy R Pettit, et al.
Clinical Parkinsonism & Related Disorders|July 28, 2021
Use of a medication-based algorithm to identify advanced Parkinson's disease in administrative claims data: Associations with claims-based indicators of disease severityNabila Dahodwala, Amy R Pettit, Jordan Jahnke, et al.
The Journal of Applied Research on Children : Informing Policy for Children at Risk|March 8, 2023
A mixed methods evaluation of parents' perspectives on the acceptability of the S.A.F.E. Firearm programKatelin Hoskins, Christina Johnson, Molly Davis, et al.
Pageof 4

Showing results (11-20 of 31) with videos related to

Sort By:
Pageof 4
The American Journal of Managed Care|March 30, 2016
Impact of cost sharing on specialty drug utilization and outcomes: a review of the evidence and future directionsJalpa A Doshi, Pengxiang Li, Vrushabh P Ladage, et al.
Journal of Clinical Psychopharmacology|June 16, 2015
Concurrent Oral Antipsychotic Drug Use Among Schizophrenia Patients Initiated on Long-Acting Injectable Antipsychotics Post-Hospital DischargeJalpa A Doshi, Amy R Pettit, Jeffrey J Stoddard, et al.
The American Journal of Managed Care|April 13, 2018
Reducing out-of-pocket cost barriers to specialty drug use under Medicare Part D: addressing the problem of "too much too soon"Jalpa A Doshi, Pengxiang Li, Amy R Pettit, et al.
Hospital Pediatrics|October 21, 2021
Depression and Anxiety Symptoms During and After Pediatric Asthma HospitalizationHaley Morin, Diana Worsley, Xuemei Zhang, et al.
Health Services Research|July 25, 2017
Impact of Cost-Sharing Increases on Continuity of Specialty Drug Use: A Quasi-Experimental StudyPengxiang Li, Tianyan Hu, Xinyan Yu, et al.
The American Journal of Managed Care|June 9, 2016
High cost sharing and specialty drug initiation under Medicare Part D: a case study in patients with newly diagnosed chronic myeloid leukemiaJalpa A Doshi, Pengxiang Li, Hairong Huo, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|March 2, 2020
Trends and Factors Associated With Insurer Approval of Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitor PrescriptionsJalpa A Doshi, Pengxiang Li, Justin T Puckett, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|June 15, 2022
Stakeholder Perspectives on MAPSAmanda L Sanchez, Katelin Hoskins, Amy R Pettit, et al.
Clinical Parkinsonism & Related Disorders|July 28, 2021
Use of a medication-based algorithm to identify advanced Parkinson's disease in administrative claims data: Associations with claims-based indicators of disease severityNabila Dahodwala, Amy R Pettit, Jordan Jahnke, et al.
The Journal of Applied Research on Children : Informing Policy for Children at Risk|March 8, 2023
A mixed methods evaluation of parents' perspectives on the acceptability of the S.A.F.E. Firearm programKatelin Hoskins, Christina Johnson, Molly Davis, et al.
Pageof 4